Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO16235-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Methods of enhancing the potency of incretin-based drugs in subjects

The present invention relates to methods of enhancing the potency of incretin-based drugs in subjects in need thereof. Through different animal […]

BIO07572-T1

Drug Field of development:

Osteoporosis / Post Menopausal Osteoporosis Therapy Area:

Target Type of patent:

Treatment of bone mineral density related diseases

The present invention relates to methods of the treatment and diagnosis of bone mineral density related disorders. More particularly, the present […]

BIO18132-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Method Type of patent:

Use of shp2 inhibitors for the treatment of insulin resistance

Despite reaching an epidemic status worldwide, metabolic disorders, notably diabetes, still miss efficient and specific therapeutic strategies because […]

BIO20193-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Method Type of patent:

Methods and pharmaceutical compositions for the treatment of chronic

The present invention relates to methods and pharmaceutical compositions for the treatment of chronic kidney disease. The inventors used the CMap […]

BIO19113-T1

Drug Field of development:

Obesity Therapy Area:

Method Type of patent:

Use of an agent capable of inhibiting the activation of mait cells for

Obesity is associated with low-grade inflammation in adipose tissue (AT) and dysfunctional adipocytes producing inflammatory molecules. A recent study […]

BIO15274-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Methods and pharmaceutical compositions for inducing immune tolerance

The present invention relates to methods and pharmaceutical compositions of inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. […]

BIO17684-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from pcsk2 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β-cell destruction in type 1 diabetes (T1D), none of their target […]

BIO17685-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β- cell destruction in type 1 diabetes (T1D), none of their target […]

BIO17382-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from secretogranin v and uses thereof for

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β- cell destruction in type 1 diabetes (T1D), none of their target […]

BIO21063-T1

Metabolic Disorders Therapy Area:

Method Type of patent:

Use of tnf-alpha blocking agent for preventing, suppressing and/or

Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of pancreatic β-cells producing insulin. Both T1D patients and animal models […]

147

56

310

46

Our Technology Offers

Methods of enhancing the potency of incretin-based drugs in subjects

Treatment of bone mineral density related diseases

Use of shp2 inhibitors for the treatment of insulin resistance

Methods and pharmaceutical compositions for the treatment of chronic

Use of an agent capable of inhibiting the activation of mait cells for

Methods and pharmaceutical compositions for inducing immune tolerance

Antigenic peptides deriving from pcsk2 and uses thereof for the

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Antigenic peptides deriving from secretogranin v and uses thereof for

Use of tnf-alpha blocking agent for preventing, suppressing and/or

You might also be interested in

Mkpatentcrmfinalmarket

Testsynchrotheracrm1904

Cd38 as a biomarker and biotarget in

Methods of enhancing the potency of incretin-based

Apelin analogs for the treatment of heart failure

Monoacylglycerol lipase as target for the

Treatment of bone mineral density related diseases

Methods and compositions for treating skin

Use of coumarin derivatives for the preparation of

Methods and compositions for treating cell

Ctip fusion to cas9 enhances transgene integration

In vitro tests allowing to identify the potential